OC
ABBV icon

Opinicus Capital’s AbbVie ABBV Stock Holding History

Opinicus Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Sell
10,651
-58
-0.5% -$12.5K 1.43% 21
2026
Q1 		$2.33M Buy
10,709
+165
+2% +$36.6K 1.64% 18
2025
Q4 		$2.41M Sell
10,544
-408
-4% -$92.9K 1.68% 14
2025
Q3 		$2.54M Buy
10,952
+714
+7% +$145K 1.76% 13
2025
Q2 		$1.9M Buy
10,238
+769
+8% +$143K 1.44% 17
2025
Q1 		$1.98M Buy
9,469
+252
+3% +$49K 1.75% 13
2024
Q4 		$1.64M Buy
9,217
+458
+5% +$84.2K 1.38% 19
2024
Q3 		$1.73M Buy
8,759
+4
+0% +$747 1.38% 19
2024
Q2 		$1.5M Buy
8,755
+381
+5% +$63.1K 1.27% 22
2024
Q1 		$1.52M Buy
8,374
+11
+0.1% +$1.9K 1.35% 19
2023
Q4 		$1.3M Buy
+8,363
New +$1.22M 1.32% 18

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Opinicus Capital's ABBV Position: Q2 2026 in Review

Opinicus Capital reduced its AbbVie (ABBV) stake by 0.54% in Q2 2026, selling an estimated $12.5K and leaving 10,651 shares worth $2.68M. The position accounts for 1.43% of the portfolio, ranked #21.

Opinicus Capital first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Opinicus Capital held 10,651 shares of AbbVie worth $2.68M as of Q2 2026.
  • Opinicus Capital sold 58 AbbVie shares in Q2 2026, an estimated $12.5K.
  • AbbVie made up 1.43% of Opinicus Capital's portfolio in Q2 2026, its #21 holding.
  • Opinicus Capital first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Opinicus Capital's 13F filing for Q2 2026, filed 27 Jul 2026.